Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus - Archive ouverte HAL Access content directly
Journal Articles Journal of Clinical and Cellular Immunology Year : 2015

Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus

(1) , (1) , (1) , (2) , (1) , (1)
1
2

Abstract

Antitumor virotherapy is a developing approach to treat cancer with oncolytic viruses, namely replicative viruses that exclusively or preferentially infect and kill tumor cells. Attenuated strains of Measles Virus (MV) are now being used as oncolytic viruses in clinical trials to treat several types of cancer. The efficacy of oncolytic viruses is mainly due to their capacity to infect and kill tumor cells, but it has also been demonstrated that their capacity to induce immunogenic cell death can activate an antitumor immune response. In this review, we describe the oncolytic capacity of MV and the concept of Immunogenic Cell Death (ICD). We then review how MV induces immunogenic cell death, which can be beneficial for cancer treatment.
Fichier principal
Vignette du fichier
induction-of-immunogenic-tumor-cell-death-by-attenuated-oncolytic-measles-virus-2155-9899-1000291.pdf (306.63 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-01148993 , version 1 (06-05-2015)

Identifiers

Cite

Carole Achard, Nicolas Boisgerault, Tiphaine Delaunay, Frédéric Tangy, Marc Grégoire, et al.. Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus. Journal of Clinical and Cellular Immunology, 2015, 6 (1), http://omicsonline.org/open-access/induction-of-immunogenic-tumor-cell-death-by-attenuated-oncolytic-measles-virus-2155-9899-1000291.php?aid=38192. ⟨10.4172/2155-9899.1000291⟩. ⟨inserm-01148993⟩
182 View
247 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More